Among 42 cancer patients treated with a protocol combining Ivermectin (25 mg) and Mebendazole (1,250 mg), the following outcomes were reported after three months:
89.4% reportedly experienced clinical benefit.
68.4% reportedly showed tumor reduction or had no detectable disease.
Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation.
Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The National Cancer Institute needs to move on this now.
Join the Fight: https://t.co/rvCeXmwbdp
Courtesy of Real America's Voice @RealAmVoice, American Sunrise
#MedicalFreedom
Do you know of febendazole?
Fenbendazole has attracted interest in research for its potential role in cancer treatment and more clinical research in parasite cleansing
Hello everyone! π¦
Get readyβyour orders will be delivered to your doorstep or mailbox by tomorrow.
We're still accepting orders! If you're interested in making a purchase, send me a direct message, and I'll make sure your order is included in tomorrow's delivery.
Castor oil, derived from the seeds of the Ricinus communis plant, has been studied for its potential anti-cancer properties. Some research has proved that castor oil can:
1. Inhibit cancer cell growth Castor stop cancer cell proliferation.
2. Induce apoptosis of cancer cells